Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-12-08
2008-03-25
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S375000, C514S378000, C514S381000, C514S621000, C544S105000, C548S230000, C548S245000, C548S253000, C564S169000
Reexamination Certificate
active
07348322
ABSTRACT:
The present invention relates to compounds of formula I:wherein A, X, R1, R2and R3are as defined herein and pharmaceutically acceptable salts thereof. The invention also relates to methods of using the compounds of formula I and pharmaceutical compositions comprising the compounds of formula I.
REFERENCES:
patent: 6245804 (2001-06-01), Lehmann et al.
patent: 6323199 (2001-11-01), Lehmann et al.
patent: 6344454 (2002-02-01), Lehmann et al.
patent: 6380207 (2002-04-01), Coghlan et al.
patent: 6548534 (2003-04-01), Lehmann et al.
patent: 6903215 (2005-06-01), Betageri et al.
patent: 2002/0077356 (2002-06-01), Jaroch et al.
patent: 2004/0254249 (2004-12-01), Jaroch et al.
patent: WO 98/54159 (1998-12-01), None
patent: WO 02/10143 (2002-02-01), None
Betageri, R., et. al., “Trifluoromethyl Group as a Pharmacophore: Effect of Replacing a CF3Group on Binding and Agonist Activity of a Glucocorticoid Receptor Ligand,”Bioorg. Med. Chem. Lett. (2005) 15, pp. 4761-4769.
Barnes, P.J., “Anti-inflammatory actions of glucocorticoids: molecular mechanisms”,Clinical Science(1998) 94, 557-572.
Schacke, H. et al., “Mechanisms involved in the side effects of glucocorticoids”,Pharmacology&Therapeutics(2002) 96, 23-42.
Heck, S. et al., “A distinct modulating domain in glucorticoid receptor monomers in the repression of activity of the transcription factor AP-1”,EMBO J., 1994 vol. 13 (17) pp. 4087-4095.
Prakash, G.K.S. et al., “Perfluoroalkylation with Organosilicon Reagents”,Chem. Rev. 1997, 97, pp. 757-786.
Ramalah, P. et al., “Direct Trifluoromethylation of a-Keto Esters to b,b,b-Trifluorolactic Acid Derivates Using Trifluoromethyltrimethylsilane”,Synlett, 1991 (09), pp. 643-644.
Reichardt, H.M. et al., “DNA Binding of the Glucocorticoid Receptor is Not Essential for Survival”,Cell, 1998 vol. 93, pp. 531-541.
Tronche, F. et al., “Genetic dissection of Glucocorticoid receptor function in mice”,Curr Opin Genet Dev., 1998, 8 (5) pp. 532-538.
Gong Leyi
O'Yang Counde
Tan Yun-chou
Chang David J.
Habte Kahsay
Roche Palo Alto LLC
LandOfFree
Glucocorticoid receptor modulators as antiinflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucocorticoid receptor modulators as antiinflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucocorticoid receptor modulators as antiinflammatory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3968585